THE 7 ESSENTIALS OF SUCCESSFUL HEALTH ECONOMIC COMMUNICATION

Monday, May 17, 2010
7:00AM-8:00AM

Sponsored by Medaxial
     

Symposia are free and open to all ISPOR delegates, no pre-registration required.

In an era of extreme pressure on healthcare spending, the role of health economists has never been more important.   Yet the contribution health economists can make to rational resource use is undermined by incomprehension, skepticism and even hostility from many outsiders – including colleagues, commentators and healthcare decision-makers.  But what exactly is it that makes health economics so hard to communicate? And what can be done to address the problem?  The 7 essential principles of successful health economic communication will be presented.

Speakers:
John Fanshawe, Co-Principal, Medaxial Group, London, UK.
Alison Begg PhD, Senior Consultant, Medaxial Group, London, UK.
Tammy Wynne, Value Communication Consultant, Medaxial Group, London, UK.

WILL COMPARATIVE EFFECTIVENESS RESEARCH SURVIVE HEALTH REFORM?

Monday, May 17, 2010
12:30PM-1:30PM

Sponsored by IMS Health
     

Symposia are free and open to all ISPOR delegates, no pre-registration required.

The Comparative Effectiveness Research (CER) movement was (re)triggered by $1.1B in funding from the government stimulus package. An increasing number of stakeholders have called for more CER research to aid payer, provider and patient decision making. However, while both the Senate and House health reform bills contained mechanisms of on-going government funding of CER, the future of such reform (and hence public funding for CER) is uncertain. In addition, the draft 2011 federal budget calls for AHRQ's CER funding to grow tenfold in 2011. Whether this will survive intact is also an open question. The question now is will the Federally-funded CER movement lose momentum, and if so, is there sufficient momentum from academics, research groups, payers and even pharmaceutical and other manufacturers to keep the movement alive. And, what will CER in the post-health reform era look like?

Three speakers representing organizations with an interest in CER research – a payer-funded organization, a not-for-profit research group and a research-oriented group representing the pharmaceutical industry, will preview how CER may evolve in the post-health reform era. This IMS Health sponsored symposium explores the future of CER research in the United States and implications for the global market place.